Liposomes (phospholipid bilayer vesicles) are versatile and robust delivery systems for
induction of antibody and T lymphocyte responses to associated subunit antigens. In the last …

Liposomes are widely utilized as a carrier to improve therapeutic efficacy of agents thanks to
their merits of high loading capacity, targeting delivery, reliable protection of agents, good …

Among the various particulate delivery systems, liposomes—bubble-like nano/microsized
lipidic bilayer structures—have shown great promise as an antigen-carrying vehicle. Few …

Cationic liposomes are lipid-bilayer vesicles with a positive surface charge that have re-
emerged as a promising new adjuvant technology. Although there is some evidence that …

Introduction: Liposomes remain at the forefront of drug and vaccine design owing to their
well-documented abilities to act as delivery vehicles. Nevertheless, the concept of liposomes …

The discovery of liposomes in 1965 by Bangham and coworkers changed the prospects of
drug delivery systems. Since then, the application of liposomes as vaccine delivery systems …

Liposomes not only offer the ability to enhance drug delivery, but can effectively act as
vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and …

Liposomes (lipid-based vesicles) have been widely studied as drug delivery systems due to
their relative safety, their structural versatility concerning size, composition and bilayer …

The development of subunit vaccines has become very attractive in recent years due to their
superior safety profiles as compared to traditional vaccines based on live attenuated or …

The application of cationic liposomes as vaccine delivery systems and adjuvants has been
investigated extensively over the last few decades. However, cationic liposomes are, in …